Cefuroxime (As Sodium) 750mg Powder for Injection IM/IV Philippines - English - FDA (Food And Drug Administration)

cefuroxime (as sodium) 750mg powder for injection im/iv

kdc pharmvet inc - cefuroxime (as sodium) - powder for injection im/iv - 750mg

Cefuroxime (As Sodium) -DRP-2584 500 mg Film-Coated Tablet Philippines - English - FDA (Food And Drug Administration)

cefuroxime (as sodium) -drp-2584 500 mg film-coated tablet

j.m. tolmann laboratories inc - cefuroxime (as sodium) - film-coated tablet - 500 mg

PHARMACOR CEFUROXIME cefuroxime 250mg film coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor cefuroxime cefuroxime 250mg film coated tablet blister pack

pharmacor pty ltd - cefuroxime axetil, quantity: 300.715 mg - tablet, film coated - excipient ingredients: crospovidone; calcium carbonate; microcrystalline cellulose; calcium stearate; croscarmellose sodium; purified water; colloidal anhydrous silica; sodium lauryl sulfate; titanium dioxide; hypromellose; propylene glycol; brilliant blue fcf aluminium lake - cefuroxime is indicated for the treatment of the following mild to moderately severe infections in adults caused by sensitive bacteria: acute upper respiratory infections: otitis media, sinusitis, tonsillitis and pharyngitis. acute exacerbations of chronic bronchitis, or acute bronchitis. skin and skin structure infections for example, furunculosis, pyoderma and impetigo. acute uncomplicated gonococcal urethritis, and cervicitis due to non-penicillinase producing gonococci.

PHARMACOR CEFUROXIME cefuroxime 500mg film coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor cefuroxime cefuroxime 500mg film coated tablet blister pack

pharmacor pty ltd - cefuroxime axetil, quantity: 601.43 mg - tablet, film coated - excipient ingredients: crospovidone; calcium stearate; purified water; colloidal anhydrous silica; calcium carbonate; microcrystalline cellulose; sodium lauryl sulfate; croscarmellose sodium; titanium dioxide; hypromellose; propylene glycol; brilliant blue fcf aluminium lake - cefuroxime is indicated for the treatment of the following mild to moderately severe infections in adults caused by sensitive bacteria: acute upper respiratory infections: otitis media, sinusitis, tonsillitis and pharyngitis. acute exacerbations of chronic bronchitis, or acute bronchitis. skin and skin structure infections for example, furunculosis, pyoderma and impetigo. acute uncomplicated gonococcal urethritis, and cervicitis due to non-penicillinase producing gonococci.

AL-Cefuroxime cefuroxime 250mg film coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

al-cefuroxime cefuroxime 250mg film coated tablet blister pack

pharmacor pty ltd - cefuroxime axetil, quantity: 300.715 mg - tablet, film coated - excipient ingredients: crospovidone; croscarmellose sodium; calcium carbonate; calcium stearate; purified water; colloidal anhydrous silica; microcrystalline cellulose; sodium lauryl sulfate; titanium dioxide; hypromellose; propylene glycol; brilliant blue fcf aluminium lake - cefuroxime is indicated for the treatment of the following mild to moderately severe infections in adults caused by sensitive bacteria: acute upper respiratory infections: otitis media, sinusitis, tonsillitis and pharyngitis. acute exacerbations of chronic bronchitis, or acute bronchitis. skin and skin structure infections for example, furunculosis, pyoderma and impetigo. acute uncomplicated gonococcal urethritis, and cervicitis due to non-penicillinase producing gonococci.

AL-Cefuroxime cefuroxime 500mg film coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

al-cefuroxime cefuroxime 500mg film coated tablet blister pack

pharmacor pty ltd - cefuroxime axetil, quantity: 601.43 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; crospovidone; calcium stearate; microcrystalline cellulose; sodium lauryl sulfate; purified water; calcium carbonate; croscarmellose sodium; titanium dioxide; hypromellose; propylene glycol; brilliant blue fcf aluminium lake - cefuroxime is indicated for the treatment of the following mild to moderately severe infections in adults caused by sensitive bacteria: acute upper respiratory infections: otitis media, sinusitis, tonsillitis and pharyngitis. acute exacerbations of chronic bronchitis, or acute bronchitis. skin and skin structure infections for example, furunculosis, pyoderma and impetigo. acute uncomplicated gonococcal urethritis, and cervicitis due to non-penicillinase producing gonococci.

Cefuroxime 250mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

cefuroxime 250mg tablets

alliance healthcare (distribution) ltd - cefuroxime axetil - oral tablet - 250mg